Kamperos G, Nikitakis N, Sfakianou A, Avgoustidis D, Sklavounou-Andrikopoulou A. Expression of NF-κB and IL-6 in oral precancerous and cancerous lesions: An immunohistochemical study. Med Oral Patol Oral Cir Bucal. 2016 Jan 1;21 (1):e6-13.

doi:10.4317/medoral.20570

http://dx.doi.org/doi:10.4317/medoral.20570

1. Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med. 2008;37:127-33.
http://dx.doi.org/10.1111/j.1600-0714.2007.00584.x

2. Warnakulasuriya S. Histological grading of oral epithelial dysplasia: revisited. J Pathol. 2001;194:294-7.
http://dx.doi.org/10.1002/1096-9896(200107)194:3<294::AID-PATH911>3.0.CO;2-Q

3. Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell. 2005;7:211-7.
http://dx.doi.org/10.1016/j.ccr.2005.02.013

4. Ara T, Declerck YA. Interleukin-6 in bone metastasis and cancer progression. Eur J Cancer. 2010;46:1223-31.
http://dx.doi.org/10.1016/j.ejca.2010.02.026

5. Chen Z, Malhotra PS, Thomas GR, Ondrey FG, Duffey DC, Smith CW, et al. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res. 1999;5:1369-79.

6. Porta C, Larghi P, Rimoldi M, Totaro MG, Allevena P, Mantovani A, et al. Cellular and molecular pathways linking inflammation and cancer. Immunobiol. 2009;214:761-77.
http://dx.doi.org/10.1016/j.imbio.2009.06.014

7. Squarize CH, Castilho RM, Sriuranpong V, Pinto DS Jr, Gutkind JS. Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma. Neoplasia. 2006;8:733-46.
http://dx.doi.org/10.1593/neo.06274

8. Baud V, Karin M. Is NF-kappaB a good target for cancer therapy?. Hopes and pitfalls. Nat Rev Drug Discov. 2009;8:33-40.
http://dx.doi.org/10.1038/nrd2781

9. Hodge DR, Hurt EM, Farrar WL. The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer. 2005;41:2502-12.
http://dx.doi.org/10.1016/j.ejca.2005.08.016

10. Hammacher A, Ward LD, Weinstock J. Structure-function analysis of human IL-6: identification of two distinct regions that are important for receptor binding. Protein Sci. 1994;3:2280-93.
http://dx.doi.org/10.1002/pro.5560031213

11. Mishra A, Bharti AC, Varghese P, Saluja D, Das BC. Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection. Int J Cancer. 2006;119:2840-50.
http://dx.doi.org/10.1002/ijc.22262

12. Fukuda M, Ehara M, Suzuki S, Ohmori Y, Sakashita H. IL-23 promotes growth and proliferation in human squamous cell carcinoma of the oral cavity. Int J Oncol. 2010;36:1355-65.
http://dx.doi.org/10.3892/ijo_00000620

13. Nakayama H, Ikebe T, Beppu M, Shirasuna K. High expression levels of nuclear factor kappaB, IkappaB kinase alpha and Akt kinase in squamous cell carcinoma of the oral cavity. Cancer. 2001;92:3037-44.
http://dx.doi.org/10.1002/1097-0142(20011215)92:12<3037::AID-CNCR10171>3.0.CO;2-#

14. Bindhu OS, Ramadas K, Sebastian P, Pillai MR. High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinoma. Head Neck. 2006;28:916-25.
http://dx.doi.org/10.1002/hed.20437

15. Santhi WS, Sebastian P, Varghese BT, Prakash O, Pillai MR. NF-kappaB and COX-2 during oral tumorigenesis and in assessment of minimal residual disease in surgical margins. Exp Mol Pathol. 2006;81:123-30.
http://dx.doi.org/10.1016/j.yexmp.2006.05.001

16. Sawhney M, Rohatgi N, Kaur J, Shishodia S, Sethi G, Gupta SD, et al. Expression of NF-kappaB parallels COX-2 expression in oral precancer and cancer: association with smokeless tobacco. Int J Cancer. 2007;120:2545-56.
http://dx.doi.org/10.1002/ijc.22657

17. Brozek W, Bises G, Fabjani G, Cross HS, Peterlik M. Clone-specific expression, transcriptional regulation, and action of interleukin-6 in human colon carcinoma cells. BMC Cancer. 2008;18:13-20.
http://dx.doi.org/10.1186/1471-2407-8-13

18. Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, Vallabhapurapu S, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 2009;15:103-13.
http://dx.doi.org/10.1016/j.ccr.2009.01.001

19. Inokuchi J, Lau A, Tyson DR, Ornstein DK. Loss of annexin A1 disrupts normal prostate glandular structure by inducing autocrine IL-6 signaling. Carcinogenesis. 2009;30:1082-8.
http://dx.doi.org/10.1093/carcin/bgp078

20. Wang YF, Chang SY, Tai SK, Li WY, Wang LS. Clinical significance of interleukin-6 and interleukin-6 receptor expressions in oral squamous cell carcinoma. Head Neck. 2002;24:850-8.
http://dx.doi.org/10.1002/hed.10145

21. Shibahara T, Nomura T, Cui NH, Noma H. A study of osteoclast-related cytokines in mandibular invasion by squamous cell carcinoma. Int J Oral Maxillofac Surg. 2005;34:789-93.
http://dx.doi.org/10.1016/j.ijom.2005.03.008

22. Shinriki S, Jono H, Ota K, Ueda M, Kudo M, Ota T, et al. Humanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinoma. Clin Cancer Res. 2009;15:5426-34.
http://dx.doi.org/10.1158/1078-0432.CCR-09-0287

23. Van Tubergen E, Vander Broek R, Lee J, Wolf G, Carey T, Bradford C, et al. Tristetraprolin regulates interleukin-6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma. Cancer. 2011;117:2677-89.
http://dx.doi.org/10.1002/cncr.25859

24. Kayamori K, Sakamoto K, Nakashima T, Takayanagi H, Morita K, Omura K, et al. Roles of interleukin-6 and parathyroid hormone-related peptide in osteoclast formation associated with oral cancers: significance of interleukin-6 synthesized by stromal cells in response to cancer cells. Am J Pathol. 2010;176:968-80.
http://dx.doi.org/10.2353/ajpath.2010.090299

25. Becker C, Fantini MC, Wirtz S, Nikolaev A, Lehr HA, Galle PR, et al. IL-6 signaling promotes tumor growth in colorectal cancer. Cell Cycle. 2005;4:217-20.
http://dx.doi.org/10.4161/cc.4.2.1413

26. Huang WH, Chang MC, Tsai KS, Hung MC, Chen HL, Hung SC. Mesenchymal stem cells promote growth and angiogenesis of tumors in mice. Oncogene. 2013;32:4343-54.
http://dx.doi.org/10.1038/onc.2012.458

27. Hobisch A, Rogatsch H, Hittmair A, Fuchs D, Bartsch G Jr, Klocker H, et al. Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue. J Pathol. 2000;191:239-44.
http://dx.doi.org/10.1002/1096-9896(2000)9999:9999<::AID-PATH633>3.0.CO;2-X

28. Matsumoto S, Hara T, Mitsuyama K, Yamamoto M, Tsuruta O, Sata M, et al. Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model. J Immunol. 2010;184:1543-51.
http://dx.doi.org/10.4049/jimmunol.0801217

29. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci. 2008;13:453-61.
http://dx.doi.org/10.2741/2692

30. Molinolo AA, Amornphimoltham P, Squarize CH, Castilho RM, Patel V, Gutkind JS. Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol. 2009;45:324-34.
http://dx.doi.org/10.1016/j.oraloncology.2008.07.011